On-label compared to off-label four-factor prothrombin complex concentrate use: a retrospective, observational study.
Brian C ChoYoun-Hoa JungVincent M DeMarioEdward LauStanley J PodlasekMichael C GrantEric A GehrieSteven M FrankPublished in: Transfusion (2019)
4F-PCC is an effective but expensive treatment option for those requiring urgent reversal of vitamin K antagonist-induced coagulopathy. However, providers should be conscious of the high costs and questionable efficacy when using 4F-PCC off-label.